Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus

References

• Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963–721. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963–72
   PubMed Web of Science ®Google Scholar
• Grant RW, Wexler DJ, Watson AJ, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care 2007;30:1448–532. Grant RW, Wexler DJ, Watson AJ, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care 2007;30:1448–53
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin R, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673–93. Peyrot M, Rubin R, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673–9
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495–74. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495–7
   PubMed Web of Science ®Google Scholar
• Stocki K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133–465. Stocki K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133–46
   PubMed Web of Science ®Google Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;9:1498–5056. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;9:1498–505
   Web of Science ®Google Scholar
• Kortykowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injections in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;11:2836–487. Kortykowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injections in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;11:2836–48
   Google Scholar
• Lee WC, Balu S, Cobden D, et al. Medication adherence and associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed claims data. Clin Ther 2006;28:1712–258. Lee WC, Balu S, Cobden D, et al. Medication adherence and associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed claims data. Clin Ther 2006;28:1712–25
   PubMed Web of Science ®Google Scholar
• Shelmet J, Schwartz S, Cappleman J, et al. Preference and resource utilization in elderly patients: Innolet vs. vial/syringe. Diabetes Res Clin Practice 2004;1:27–359. Shelmet J, Schwartz S, Cappleman J, et al. Preference and resource utilization in elderly patients: Innolet vs. vial/syringe. Diabetes Res Clin Practice 2004;1:27–35
   Google Scholar
• Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0 mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049–6710. Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0 mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049–67
   PubMed Web of Science ®Google Scholar
• Segal R, Helper CD. Drug choice as a problem-solving process. Med Care 1985;23:967–611. Segal R, Helper CD. Drug choice as a problem-solving process. Med Care 1985;23:967–6
   PubMed Web of Science ®Google Scholar
• Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998;21:1391–612. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998;21:1391–6
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430–213. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430–2
   PubMed Web of Science ®Google Scholar
• Glickman L, Bruce EA, Caro FG, et al. Physicians’ knowledge of drug costs for the elderly. J Am Geriatrics Soc 1994;42:992–614. Glickman L, Bruce EA, Caro FG, et al. Physicians’ knowledge of drug costs for the elderly. J Am Geriatrics Soc 1994;42:992–6
   PubMed Web of Science ®Google Scholar
• Buchsbaum DG, Clancy CM, Centor RM, et al. House officer attitudes, beliefs, and recording behavior associated with prescribing minor tranquilizers. Teaching Learning Med 1990;2:30–315. Buchsbaum DG, Clancy CM, Centor RM, et al. House officer attitudes, beliefs, and recording behavior associated with prescribing minor tranquilizers. Teaching Learning Med 1990;2:30–3
   Google Scholar
• Turk DC, Okifugi A. What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain 1997;13:330–616. Turk DC, Okifugi A. What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain 1997;13:330–6
   Google Scholar
• Paredes P, De la Pena M, Flores-Guerra E, et al. Factors influencing physicians’ prescribing behavior in the treatment of childhood diarrhoea: knowledge may not be the clue. Soc Sci Med 1996;42:1141–5317. Paredes P, De la Pena M, Flores-Guerra E, et al. Factors influencing physicians’ prescribing behavior in the treatment of childhood diarrhoea: knowledge may not be the clue. Soc Sci Med 1996;42:1141–53
   PubMed Web of Science ®Google Scholar
• Larue F, Colleau SM, Fontaine A, et al. Oncologists and primary care physicians’ attitudes toward pain control and morphine prescribing in France. Cancer 1995;76:2375–8218. Larue F, Colleau SM, Fontaine A, et al. Oncologists and primary care physicians’ attitudes toward pain control and morphine prescribing in France. Cancer 1995;76:2375–82
   PubMed Web of Science ®Google Scholar
• Isacsson G, Bergman U, Wasserman D, et al. The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiatry 1996;8:153–6019. Isacsson G, Bergman U, Wasserman D, et al. The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiatry 1996;8:153–60
   PubMedGoogle Scholar
• Cormack MA, Howells E. Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Fam Practice 1992;9:466–7120. Cormack MA, Howells E. Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Fam Practice 1992;9:466–71
   PubMed Web of Science ®Google Scholar
• Virji A, Britten N. A study of the relationship between patients’ attitudes and doctors’ prescribing. Fam Practice 1991;8:314–921. Virji A, Britten N. A study of the relationship between patients’ attitudes and doctors’ prescribing. Fam Practice 1991;8:314–9
   PubMed Web of Science ®Google Scholar
• Hadsall RS, Freeman RA, Norwood GJ. Factors related to the prescribing of selected psychotropic drugs by primary care physicians. Soc Sci Med 1982;16:1747–5622. Hadsall RS, Freeman RA, Norwood GJ. Factors related to the prescribing of selected psychotropic drugs by primary care physicians. Soc Sci Med 1982;16:1747–56
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: The Insulin Delivery System Rating Questionnaire. Diabetes Care 2005;28:53–823. Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: The Insulin Delivery System Rating Questionnaire. Diabetes Care 2005;28:53–8
   PubMed Web of Science ®Google Scholar
• Wanberg CR, Banas JT. Predictors of outcomes and openness to changes in a reorganizing workplace. J Applied Psychol 2000;85:132–4224. Wanberg CR, Banas JT. Predictors of outcomes and openness to changes in a reorganizing workplace. J Applied Psychol 2000;85:132–42
   PubMed Web of Science ®Google Scholar
• de Costa S, Brackenridge B, Hicks D. A comparison of insulin pen usage in the United States and the United Kingdom. Diabetes Educ 2002;28:52–6025. de Costa S, Brackenridge B, Hicks D. A comparison of insulin pen usage in the United States and the United Kingdom. Diabetes Educ 2002;28:52–60
   PubMed Web of Science ®Google Scholar
• Bull SA, Hu H, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient–physician communication. J Am Med Assoc 2002;288:1403–926. Bull SA, Hu H, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient–physician communication. J Am Med Assoc 2002;288:1403–9
   PubMed Web of Science ®Google Scholar
• Robinson W. Ecological correlations and the behavior of individuals. Am Soc Rev 1950;15:351–727. Robinson W. Ecological correlations and the behavior of individuals. Am Soc Rev 1950;15:351–7
   Web of Science ®Google Scholar
• Pawaskar MD, Camancho FT, Anderson RT, et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther 2007;29:1294–30528. Pawaskar MD, Camancho FT, Anderson RT, et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther 2007;29:1294–305
   Web of Science ®Google Scholar